IBDEI2L2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43330,0)
 ;;=Z83.6^^197^2185^39
 ;;^UTILITY(U,$J,358.3,43330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43330,1,3,0)
 ;;=3^Family Hx of Respiratory System Diseases
 ;;^UTILITY(U,$J,358.3,43330,1,4,0)
 ;;=4^Z83.6
 ;;^UTILITY(U,$J,358.3,43330,2)
 ;;=^5063385
 ;;^UTILITY(U,$J,358.3,43331,0)
 ;;=Z82.62^^197^2185^37
 ;;^UTILITY(U,$J,358.3,43331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43331,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,43331,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,43331,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,43332,0)
 ;;=Z83.41^^197^2185^35
 ;;^UTILITY(U,$J,358.3,43332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43332,1,3,0)
 ;;=3^Family Hx of Multiple Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,43332,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,43332,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,43333,0)
 ;;=Z83.49^^197^2185^10
 ;;^UTILITY(U,$J,358.3,43333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43333,1,3,0)
 ;;=3^Family Hx of Endo,Nutritional & Metabolic Diseases
 ;;^UTILITY(U,$J,358.3,43333,1,4,0)
 ;;=4^Z83.49
 ;;^UTILITY(U,$J,358.3,43333,2)
 ;;=^5063381
 ;;^UTILITY(U,$J,358.3,43334,0)
 ;;=Z81.0^^197^2185^17
 ;;^UTILITY(U,$J,358.3,43334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43334,1,3,0)
 ;;=3^Family Hx of Intellectual Disabilities
 ;;^UTILITY(U,$J,358.3,43334,1,4,0)
 ;;=4^Z81.0
 ;;^UTILITY(U,$J,358.3,43334,2)
 ;;=^5063358
 ;;^UTILITY(U,$J,358.3,43335,0)
 ;;=Z84.1^^197^2185^19
 ;;^UTILITY(U,$J,358.3,43335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43335,1,3,0)
 ;;=3^Family Hx of Kidney & Ureter Disorders
 ;;^UTILITY(U,$J,358.3,43335,1,4,0)
 ;;=4^Z84.1
 ;;^UTILITY(U,$J,358.3,43335,2)
 ;;=^5063389
 ;;^UTILITY(U,$J,358.3,43336,0)
 ;;=Z84.2^^197^2185^14
 ;;^UTILITY(U,$J,358.3,43336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43336,1,3,0)
 ;;=3^Family Hx of Genitourinary System Diseases
 ;;^UTILITY(U,$J,358.3,43336,1,4,0)
 ;;=4^Z84.2
 ;;^UTILITY(U,$J,358.3,43336,2)
 ;;=^5063390
 ;;^UTILITY(U,$J,358.3,43337,0)
 ;;=Z83.1^^197^2185^16
 ;;^UTILITY(U,$J,358.3,43337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43337,1,3,0)
 ;;=3^Family Hx of Infectious & Parasitic Diseases
 ;;^UTILITY(U,$J,358.3,43337,1,4,0)
 ;;=4^Z83.1
 ;;^UTILITY(U,$J,358.3,43337,2)
 ;;=^5063377
 ;;^UTILITY(U,$J,358.3,43338,0)
 ;;=Z84.81^^197^2185^13
 ;;^UTILITY(U,$J,358.3,43338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43338,1,3,0)
 ;;=3^Family Hx of Genetic Disease Carrier
 ;;^UTILITY(U,$J,358.3,43338,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,43338,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,43339,0)
 ;;=Z83.511^^197^2185^15
 ;;^UTILITY(U,$J,358.3,43339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43339,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,43339,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,43339,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,43340,0)
 ;;=Z83.518^^197^2185^12
 ;;^UTILITY(U,$J,358.3,43340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43340,1,3,0)
 ;;=3^Family Hx of Eye Disorder
 ;;^UTILITY(U,$J,358.3,43340,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,43340,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,43341,0)
 ;;=Z83.52^^197^2185^9
 ;;^UTILITY(U,$J,358.3,43341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43341,1,3,0)
 ;;=3^Family Hx of Ear Disorder
 ;;^UTILITY(U,$J,358.3,43341,1,4,0)
 ;;=4^Z83.52
 ;;^UTILITY(U,$J,358.3,43341,2)
 ;;=^5063384
 ;;^UTILITY(U,$J,358.3,43342,0)
 ;;=Z83.71^^197^2185^4
 ;;^UTILITY(U,$J,358.3,43342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43342,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,43342,1,4,0)
 ;;=4^Z83.71
